Charting the Course for Energy Efficiency in New York: Lessons from Existing Programs

This report examines the performance of the existing suite of energy efficiency efforts run by the New York State Energy Research and Development Authority and the state’s investor owned utilities. The latest data shows that through 2014 EEPS program administrators had achieved 79 percent of their to-date savings goals. The report focuses on the best ways to transition from the EEPS program model to the emerging REV model. Reviewing publicly available information, this analysis takes stock of what the EEPS has achieved and calls for a REV planning and delivery program that builds upon lessons learned from decades of past efforts to achieve self-sustaining efficiency markets. It 1) describes the proposed changes to energy efficiency delivery currently under consideration by the Cuomo Administration, 2) reviews overall EEPS performance through the third quarter of 2014, 3) recommends a framework to serve as the basis for future decision-making, and 4) makes additional recommendations for the future of energy efficiency efforts in New York State

Veils and Cloaks of Ignorance: Under-used Tools for Conflict Resolution

Published in cooperation with the American Bar Association Section of Dispute Resolutio

Implementing Sustainable Literacy in Grand Rapids, MI

Recognizing the dimensions and complexity of wicked problems, Phoenix Farms has decided to address the issue of sustainable illiteracy in Western Michigan. With a goal to work with local stakeholders, we have partnered with Sonder Farms in order to develop advertisements and classes aimed to raise awareness about, and interest in, sustainability. This partnership with Sonder Farms, a self-sustaining farm located in the Grand Rapids and Allendale communities, has given us the opportunity to put our skills, knowledge, and values to use in our local community. Sonder Farms practices conventional farming as well as aquaponics. Their hope is to target the community by countering issues such as environmental injustice, sustainable illiteracy, economics, education, health, and much more. They plan to offer classes to the community, covering subjects such as diet/nutrition, the environment, finances, sustainable agriculture and many more. Seeking to develop ideas of mutual benefit, we worked closely with Sonder Farms in order to co-create and implement compelling and relevant action-plans. For instance, we have developed promotional materials illustrating the dimensions of sustainable illiteracy, highlighting Sonder Farms mission, and detailing the research we have conducted about downtown Grand Rapids residents. We have sought to make sustainability education accessible in the greater Grand Rapids area along four dimensions, including (1) posters (2) guerrilla advertisements, (3) the development of monthly newsletters, and (4) a plan for increasing the accessibility of Sonder Farm classes. The following describes our ultimate efforts, the process by which we came to this work, and the challenges we confronted. Through detailing our work, we hope to engage people who are enthusiastic about environmental justice, thereby increasing the chances these efforts will lead to systemic, long-term change

Regional biodiversity of terrestrial Heteroptera and Orthoptera in southwestern Illinois

We conducted a baseline inventory of terrestrial Heteroptera (true bugs) and Orthoptera (grasshoppers, crickets and katydids) at foursites in Monroe and Randolph counties,Illinois in 2014, namely: Mill Creek Natural Area (MCNA); White Rock Nature Preserve (WRNP); Fogelpole Cave Nature Preserve (FCNP); and Kidd Lake State Natural Area (KLSNA).A total of 95 species in the focal taxa were recorded (67 Heteropteraand28 Orthoptera). In addition, a further 96 species of arthropods in groups other than Heteroptera and Orthoptera were also recorded.Heteropteran diversity was found to be typical of that expected for other natural areas in Illinois, though orthopteran diversity was much lower and may be related to structural aspects of the respective habitats.Cluster analysis of our presence/absence data revealed marked differences in site similarity between orthopteran and heteropteran species assemblages.IDNR Division of Wildlifeunpublishednot peer reviewedOpe

Covid-19 public health road map: Eating behaviour

This roadmap aims to support health officials to consider changes to eating behaviour that may have occurred during the Covid-19 pandemic and to use psychologically-informed behaviour change approaches to optimise health improvement and mitigate negative eating patterns. It will focus on eating a balanced diet, as opposed to eating behaviours related to disordered eating. This guidance should be used alongside the Achieving Behaviour Change (ABC) guide {1} for local government and partners, and the Improving People’s Health behavioural and social science strategy {2} {1}https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/875385/PHEBI_Achieving_Behaviour_Change_Local_Government.pdf {2}https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/744672/Improving_Peoples_Health_Behavioural_Strategy.pd

Covid-19 public health road map: Sedentary behaviour

This roadmap aims to support health officials to consider changes to sedentary behaviour that may have occurred during the Covid-19 pandemic and to use psychologically informed behaviour change approaches to optimise health improvement and mitigate an increase in time spent sitting or lying down. This guidance should be used alongside the Achieving Behaviour Change (ABC) guide {1} for local government and partners, and the Improving People’s Health behavioural and social science strategy {2} {1}https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/875385/PHEBI_Achieving_Behaviour_Change_Local_Government.pdf {2}https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/744672/Improving_Peoples_Health_Behavioural_Strategy.pdfFinal Published versio

Covid-19 public health road map: Physical activity

This roadmap aims to support health officials to consider changes to physical activity that may have occurred during the Covid-19 pandemic and to use psychologically-informed behaviour change approaches to optimise health improvement and mitigate a reduction in activity levels. This guidance should be used alongside the Achieving Behaviour Change (ABC) guide {1} for local government and partners, and the Improving People’s Health behavioural and social science strategy {2} {1}https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/875385/PHEBI_Achieving_Behaviour_Change_Local_Government.pdf {2}https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/744672/Improving_Peoples_Health_Behavioural_Strategy.pdfFinal Published versio

A bioinventory of select terrestrial insects at Braidwood Dunes and Savanna Nature Preserve (Will County, Illinois)

We conducted an inventory of select terrestrial insect groups at Braidwood Dunes and Savanna Nature Preserve in 2011 and 2012. A total of 823 unique species, representing 19 orders of Hexapods, were recorded using a variety of sampling methods (including: light trapping, pitfall trapping, sweep net, vacuum sample, litter sample, soil core, wine rope, visual transect). Intensive studies focused on springtails (Collembola), grasshoppers, crickets and katydids (Orthoptera), true bugs (Hemiptera: Heteroptera), leafhoppers and kin (Hemiptera: Auchenorrhyncha), ground beetles (Coleoptera: Carabidae) and butterflies and macromoths (Lepidoptera). We estimate that our records comprise around 11% of the total fauna of Hexapoda that occur at this 315--‐acre site. We evaluated sampling completeness for each group and compared, richness, diversity and evenness across habitat types. Special attention was focused on midwestern remnant dependent species, conservative prairie and savanna insects of the Chicago Wilderness region, and species that appear on Illinois' list of species in greatest need of conservation. We provide the Forest Preserve District of Will County with management recommendations relating to the terrestrial for this site, as well as a large collection of images covering many of the species we encountered. Braidwood Dunes and Savanna Nature Preserve contains a variety of rare and understudied species, some of which have only infrequently been encountered. These animals play a Cover photo: Papaipema speciosissima (Noctuidae), the Osmunda Borer Moth 3 wide variety of roles within the ecosystem and various habitats, and warrant special consideration and appreciation not only by land managers but also by the members of the public with an interest in the natural world.unpublishednot peer reviewe

Immunogenicity and safety of AZD2816, a beta (B.1.351) variant COVID-19 vaccine, and AZD1222 (ChAdOx1 nCoV-19) as third-dose boosters for previously vaccinated adults:a multicentre, randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study in the UK and Poland

Background: This study aimed to evaluate AZD2816, a variant-updated COVID-19 vaccine expressing the full-length SARS-CoV-2 beta (B.1.351) variant spike protein that is otherwise similar to AZD1222 (ChAdOx1 nCoV-19), and AZD1222 as third-dose boosters.Methods: This phase 2/3, partly double-blinded, randomised, active-controlled study was done at 19 sites in the UK and four in Poland. Adult participants who had received a two-dose AZD1222 or mRNA vaccine primary series were randomly assigned by means of an Interactive Response Technology–Randomisation and Trial Supply Management system (1:1 within each primary-series cohort, stratified by age, sex, and comorbidities) to receive AZD1222 or AZD2816 (intramuscular injection; 5 × 1010 viral particles). Participants, investigators, and all sponsor staff members involved in study conduct were masked to randomisation. AZD1222 and AZD2816 doses were prepared by unmasked study staff members. The primary objectives were to evaluate safety and humoral immunogenicity (non-inferiority of day-29 pseudovirus neutralising antibody geometric mean titre [GMT] against ancestral SARS-CoV-2: AZD1222 booster vs AZD1222 primary series [historical controls]; margin 0·67; SARS-CoV-2-seronegative participants). This study is registered with ClinicalTrials.gov, NCT04973449, and is completed.Findings: Between June 27 and Sept 30, 2021, 1394 participants of the 1741 screened were randomly assigned to AZD1222 or AZD2816 following an AZD1222 (n=373, n=377) or mRNA vaccine (n=322, n=322) primary series. In SARS-CoV-2-seronegative participants receiving AZD1222 or AZD2816, 78% and 80% (AZD1222 primary series) and 90% and 93%, respectively (mRNA vaccine primary series) reported solicited adverse events to the end of day 8; 2%, 2%, 1%, and 1% had serious adverse events and 12%, 12%, 10%, and 11% had adverse events of special interest, respectively, to the end of day 180. The primary immunogenicity non-inferiority endpoint was met: day-29 neutralising antibody GMT ratios (ancestral SARS-CoV-2) were 1·02 (95% CI 0·90–1·14) and 3·47 (3·09–3·89) with AZD1222 booster versus historical controls (AZD1222 and mRNA vaccine primary series, respectively). Responses against beta were greater with AZD2816 versus AZD1222 (GMT ratios, AZD1222, mRNA vaccine primary series 1·84 [1·63–2·08], 2·22 [1·99–2·47]).Interpretation: Both boosters were well tolerated, with immunogenicity against ancestral SARS-CoV-2 similar to AZD1222 primary-series vaccination. AZD2816 gave greater immune responses against beta versus AZD1222.Funding: AstraZeneca

Immunogenicity and safety of AZD2816, a beta (B.1.351) variant COVID-19 vaccine, and AZD1222 (ChAdOx1 nCoV-19) as third-dose boosters for previously vaccinated adults: a multicentre, randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study in the UK and Poland

BACKGROUND: This study aimed to evaluate AZD2816, a variant-updated COVID-19 vaccine expressing the full-length SARS-CoV-2 beta (B.1.351) variant spike protein that is otherwise similar to AZD1222 (ChAdOx1 nCoV-19), and AZD1222 as third-dose boosters. METHODS: This phase 2/3, partly double-blinded, randomised, active-controlled study was done at 19 sites in the UK and four in Poland. Adult participants who had received a two-dose AZD1222 or mRNA vaccine primary series were randomly assigned by means of an Interactive Response Technology-Randomisation and Trial Supply Management system (1:1 within each primary-series cohort, stratified by age, sex, and comorbidities) to receive AZD1222 or AZD2816 (intramuscular injection; 5 × 1010 viral particles). Participants, investigators, and all sponsor staff members involved in study conduct were masked to randomisation. AZD1222 and AZD2816 doses were prepared by unmasked study staff members. The primary objectives were to evaluate safety and humoral immunogenicity (non-inferiority of day-29 pseudovirus neutralising antibody geometric mean titre [GMT] against ancestral SARS-CoV-2: AZD1222 booster vs AZD1222 primary series [historical controls]; margin 0·67; SARS-CoV-2-seronegative participants). This study is registered with ClinicalTrials.gov, NCT04973449, and is completed. FINDINGS: Between June 27 and Sept 30, 2021, 1394 participants of the 1741 screened were randomly assigned to AZD1222 or AZD2816 following an AZD1222 (n=373, n=377) or mRNA vaccine (n=322, n=322) primary series. In SARS-CoV-2-seronegative participants receiving AZD1222 or AZD2816, 78% and 80% (AZD1222 primary series) and 90% and 93%, respectively (mRNA vaccine primary series) reported solicited adverse events to the end of day 8; 2%, 2%, 1%, and 1% had serious adverse events and 12%, 12%, 10%, and 11% had adverse events of special interest, respectively, to the end of day 180. The primary immunogenicity non-inferiority endpoint was met: day-29 neutralising antibody GMT ratios (ancestral SARS-CoV-2) were 1·02 (95% CI 0·90-1·14) and 3·47 (3·09-3·89) with AZD1222 booster versus historical controls (AZD1222 and mRNA vaccine primary series, respectively). Responses against beta were greater with AZD2816 versus AZD1222 (GMT ratios, AZD1222, mRNA vaccine primary series 1·84 [1·63-2·08], 2·22 [1·99-2·47]). INTERPRETATION: Both boosters were well tolerated, with immunogenicity against ancestral SARS-CoV-2 similar to AZD1222 primary-series vaccination. AZD2816 gave greater immune responses against beta versus AZD1222. FUNDING: AstraZeneca